Share Email Print
cover

Proceedings Paper

Macular protection with IOLs
Author(s): Per G. Soderberg; Stefan Lofgren; Marcelo Ayala; Xiuqin Dong; Manoj Kakar; Vino Mody; Linda Meyer; Carl-Gustaf Laurell
Format Member Price Non-Member Price
PDF $14.40 $18.00

Paper Abstract

The clinical outcome within one month after phacoemulsification cataract extraction with implantation of the blue-blocking SN60AT IOL was examined prospectively and compared to a retrospectively examined material of implantations of the equivalent SA30AL without blue-blocker. There was no difference in best corrected visual acuity gain between the two lenses. In addition, the subjective color perception was examined for with a questionnaire after the first implantation of blue-blocking IOL and after the second implantation of blue-blocking IOL. Only one patient noted a changed color perception. There are thus strong theoretical reasons to block blue light in IOLs and no short term clinical inconvenience. But, it remains to be proven in long term follow up studies that the blue-blocking IOL protects against macular degeneration.

Paper Details

Date Published: 13 July 2004
PDF: 4 pages
Proc. SPIE 5314, Ophthalmic Technologies XIV, (13 July 2004); doi: 10.1117/12.540882
Show Author Affiliations
Per G. Soderberg, St. Erik's Eye Hospital (Sweden)
Univ. of Miami (United States)
Stefan Lofgren, St. Eriks Eye Hospital (Sweden)
Marcelo Ayala, St. Eriks Eye Hospital (Sweden)
Orebro Univ. Hospital (Sweden)
Xiuqin Dong, St. Erik's Eye Hospital (Sweden)
Manoj Kakar, St. Erik's Eye Hospital (Sweden)
Vino Mody, St. Erik's Eye Hospital (Sweden)
Linda Meyer, St. Erik's Eye Hospital (Sweden)
Carl-Gustaf Laurell, St. Erik's Eye Hospital (Sweden)


Published in SPIE Proceedings Vol. 5314:
Ophthalmic Technologies XIV
Fabrice Manns; Per G. Soderberg; Arthur Ho, Editor(s)

© SPIE. Terms of Use
Back to Top